GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE318nnn/GSE318304/suppl/GSE318304_RawCount_Matrix_ann.txt.gzftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE318nnn/GSE318304/primaryOK200TranscriptomicsMus musculusExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318304GEOGSEfalseRXR agonist increases newly characterized GM-CSF-producing B220+CD8αα interepithelial T cellsContext-dependent cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) plays a crucial role in maintaining intestinal immune homeostasis and exacerbating inflammation. Although multiple cell types produce GM-CSF in the gut, whether intraepithelial lymphocytes (IELs) contribute to GM-CSF production during the steady state remains unclear. In the small intestinal epithelial layer, we identified B220-expressing CD8αα T cells that selectively produced GM-CSF but not interleukin-17A or interferon-gamma. Transcriptional analysis combined with weighted parametric gene set analysis revealed the upregulation of retinoid X receptor (RXR)-related genes in this population. Consistently, the RXR agonist bexarotene increased GM-CSF-producing B220+CD8αα T cells without affecting other cytokines or CD8αβ T cells. These findings identify B220+CD8αα IELs as a spatially distinct source of GM-CSF in the epithelial layer and indicate that the RXR pathway specifically facilitates GM-CSF-producing program, potentially contributing to maintaining immune homeostasis in the small intestine.2026/06/19GSE318304GSM9492029GSM9492032GSM9492033GSM9492030GSM9492031GSM949203424247318304Mus musculus